Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.

Accepted 2022-03-10 00:00:00 ET · period of report 2022-03-08 · accession 0001567619-22-006727 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-03-10	2022-03-08	TMCI	Frias Jaime A.	CLO	A - Grant	$0.00	+7,875	50.7K	+18%	$0
D	2022-03-10	2022-03-08	TMCI	Frias Jaime A.	CLO	A - Grant	$0.00	+60.8K	60.8K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-08	A	A	7,875	$0.00	50,659	D	—	—	(F1) Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date. (F3) On April 29, 2021, a Form 4 was filed, which inadvertently reported that, following a stock split related to the Issuer's IPO, the Reporting Person directly owned 42,786 shares of Common Stock. Applying the correct stock split ratio, which rounded down fractional shares, the Reporting Person indirectly owned 42,784 shares. This correction has been reflected in this filing. (F2) Includes 7,875 RSUs.
2	Derivative	Stock Option (Right to Buy)	2022-03-08	A	A	60,800	$0.00	60,800	D	$19.15 · — to 2022-03-08	60,800 Common Stock	(F5) The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.